Business Trip
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
June 21, 2024
Greg and Matias interview Josh Hardman, founder and editor of Psychedelic Alpha, to discuss the recent FDA advisory committee meeting on Lykos Therapeutics MDMA-assisted therapy for PTSD.Josh is a leading writer covering the intersection of psychedelics
Business Trip tells the story of businesses at the frontier of mental health and wellness. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!